Citigroup’s Anixa Biosciences ANIX Stock Holding History

Citigroup’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$3	–	6045
2025 Q3	$3	Buy	+1	New	+$3	﹤0.01%	6002
2024 Q2	–	Sell	-2,087	Closed	-$6.51K	–	5568
2024 Q1	$6.51K	Buy	2,087 +567	+37%	+$2.26K	﹤0.01%	5284
2023 Q4	$5.9K	Buy	+1,520	New	+$5.13K	﹤0.01%	5307

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citigroup's ANIX Position: Q4 2025 in Review

Citigroup sold out of Anixa Biosciences (ANIX) in Q4 2025, closing a stake of 1 share — an estimated $3 sold.

Citigroup first reported a position in ANIX in Q4 2023 and held it in 3 quarters. The position peaked at $6.51K in Q1 2024. 71 funds tracked by Wall St. Rank hold ANIX as of Q4 2025.

Citigroup reported no remaining Anixa Biosciences position as of Q4 2025 after selling out during the quarter.
Citigroup sold 1 Anixa Biosciences share in Q4 2025, an estimated $3.
Citigroup first reported a position in Anixa Biosciences in Q4 2023 and held it in 3 quarters.
Citigroup's Anixa Biosciences position peaked at $6.51K in Q1 2024.
71 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.